Neonatal Medicine News

Mothers who experienced symptoms of depression near the end of their pregnancy were more likely to have children with lowered immunity than mothers without depressive symptoms, according to a study recently published in Clinical & Experimental Allergy.

WHO, CDC and the American College of Obstetricians and Gynecologists have all issued recommendations to health care professionals for the treatment of pregnant women during the COVID-19 pandemic.

In Tennessee, only 23% of infants who were exposed to hepatitis C virus were tested for it, including just one in 10 black infants, study results suggested.

The use of macrolide antibiotics during pregnancy was associated with an increased risk for major malformations — particularly cardiovascular malformations — in children, according to research published in BMJ.

Findings from a small observational study in China showed no evidence that the novel coronavirus at the center of a global outbreak is passed from mother to child during pregnancy.

Infants without congenital Zika virus who were exposed to Zika in utero are at risk for abnormal neurodevelopmental outcomes during their first 18 months of life, according to a longitudinal study published in JAMA Pediatrics.

The risk for sudden infant death syndrome, or SIDS, was nearly 12 times higher in infants with mothers who both smoked cigarettes and drank alcohol beyond the first trimester of pregnancy, according to a study published in EClinicalMedicine.

The birth defect-related infant mortality rate in the United States declined by 10% from 2003 to 2017, according to data published in MMWR.

Psychological distress in women carrying fetuses with congenital heart disease, or CHD, is associated with impaired cerebellar and hippocampal development during the second half of gestation, according to results from a study published in JAMA Pediatrics.

Treatment with high-dose erythropoietin, or EPO, is not associated with a lower risk for death or severe neurodevelopmental impairment at 2 years of age in extremely preterm infants, according to phase 3 trial results published in The New England Journal of Medicine.